L Makhlouf, K Kishimoto, RN Smith, R Abdi, … - Diabetes, 2002 - Am Diabetes Assoc Although it has often been assumed that transplanted allogeneic islets can be
destroyed by recurrent autoimmunity in recipients with type 1 diabetes,
definitive evidence is lacking and the settings in which this may occur ... Cited by 40 - Related articles - BL Direct - All 5 versions
TATCC Blockade - DIABETES, 2002 - Am Diabetes Assoc Page 1. The Role of Autoimmunity in Islet Allograft Destruction Major
Histocompatibility Complex Class II Matching Is Necessary for ... Related articles
- ►asnjournals.org L Makhlouf, A Yamada, T Ito, R Abdi, MJI … - Journal of the American Society of Nephrology, 2003 - Am Soc Nephrol Type I diabetes mellitus is an important cause of end-stage renal disease, and
islet allotransplantation, with or without kidney transplantation, offers a
potential cure for diabetes mellitus (1). Different pathways of ... Cited by 18 - Related articles - BL Direct - All 4 versions
- ►jimmunol.org TM Kupfer, ML Crawford, K Pham, RG Gill - The Journal of Immunology, 2005 - Am Assoc Immnol When transplanted into type 1a diabetic recipients, islet allografts are subject
both to conventional allograft immunity and, presumably, to recurrent autoimmune
(islet-specific) pathogenesis. Importantly, CD4 T cells play a central role ... Cited by 21 - Related articles - All 4 versions
T Okitsu, ST Bartlett, GA Hadley, CB … - American Journal of Transplantation, 2001 - anesthesia.umm.edu Recurrent autoimmunity destroys nonobese diabetic (NOD) islet isografts, but
whether recurrent autoim- munity contributes to islet graft destruction in im-
munocompetent allogeneic recipients is unknown. In the NOD, a single dose ... Cited by 18 - Related articles - View as HTML - All 9 versions
J Beilke, Z Johnson, N Kuhl, RG Gill - Transplantation proceedings, 2004 - Elsevier The purpose of this study was to determine the role for CD8 T cells versus
generalized MHC class I–restricted antigen presentation in islet allograft
rejection and tolerance. Diabetic C57BI/6 (B6, H-2 b ) controls, C57BI/6 ... Cited by 5 - Related articles - All 6 versions
- ►diabetesjournals.org RD Molano, T Berney, H Li, P Cattan, A Pileggi … - Diabetes, 2001 - Am Diabetes Assoc Allorejection and recurrence of autoimmunity are the major barriers to
transplantation of islets of Langerhans for the cure of type 1 diabetes in
humans. CD40-CD154 (CD40 ligand) interaction blockade by the use of ... Cited by 76 - Related articles - BL Direct - All 4 versions
TG Markees, DV Serreze, NE Phillips, CH … - DIABETES-NEW YORK-, 1999 - Am Diabetes Assoc A protocol consisting of a single donor-specific trans- fusion (DST) plus a
brief course of anti-CD154 mono- clonal antibody (anti-CD40 ligand mAb) induces
per- manent islet allograft survival in chemically diabetic mice, but its ... Cited by 79 - Related articles - BL Direct - All 6 versions
HY Young, P Zucker, RA Flavell, AM Jevnikar, … - Transplantation, 2004 - journals.lww.com Transplantation. Wolters Kluwer Health Logo. All Issues. ... Cited by 8 - Related articles - All 4 versions
